Standard BioTools Community

NasdaqGS:LAB Community

1 Narratives written by author
0 Comments on narratives written by author
1 Fair Values set on narratives written by author

Standard BioTools

AN

AnalystConsensusTarget

Consensus Narrative from 2 Analysts

SomaLogic Merger And Illumina Partnership Will Unlock New Proteomics Opportunities

Key Takeaways Strategic mergers and partnerships, along with cost synergies, aim to improve profitability and net margins significantly. Product integration in proteomics and genomics taps into a large market, while a focus on consumables enhances recurring revenue growth.

US$2.38

FV

51.6% undervalued

6.03%

Revenue growth p.a.

0

0

1

3 days ago